Article, 2024

Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, ISSN 0960-894X, Volume 98, 10.1016/j.bmcl.2023.129572

Contributors

Hogberg, Thomas (Corresponding author) [1] Receveur, Jean-Marie [1] Murray, Anthony [1] Linget, Jean-Michel [1] Norregaard, Pia K. [1] Little, Paul [1] Cooper, Martin [1]

Affiliations

  1. [1] 7TM Pharma AS, Horsholm, Denmark
  2. [NORA names: Other Companies; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

ADME profile, Antiobesity, CB1 antagonists and inverse agonists, Drug design, Liver distribution, Metabolic diseases, Peripheral action

Data Provider: Clarivate